Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin
- 12 January 2012
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 109 (3), E111-8
- https://doi.org/10.1073/pnas.1110740109
Abstract
Malaria, caused by Plasmodium sp, results in almost one million deaths and over 200 million new infections annually. The World Health Organization has recommended that artemisinin-based combination therapies be used for treatment of malaria. Artemisinin is a sesquiterpene lactone isolated from the plant Artemisia annua. However, the supply and price of artemisinin fluctuate greatly, and an alternative production method would be valuable to increase availability. We describe progress toward the goal of developing a supply of semisynthetic artemisinin based on production of the artemisinin precursor amorpha-4,11-diene by fermentation from engineered Saccharomyces cerevisiae, and its chemical conversion to dihydroartemisinic acid, which can be subsequently converted to artemisinin. Previous efforts to produce artemisinin precursors used S. cerevisiae S288C overexpressing selected genes of the mevalonate pathway [Ro et al. (2006) Nature 440:940-943]. We have now overexpressed every enzyme of the mevalonate pathway to ERG20 in S. cerevisiae CEN.PK2, and compared production to CEN.PK2 engineered identically to the previously engineered S288C strain. Overexpressing every enzyme of the mevalonate pathway doubled artemisinic acid production, however, amorpha-4,11-diene production was 10-fold higher than artemisinic acid. We therefore focused on amorpha-4,11-diene production. Development of fermentation processes for the reengineered CEN.PK2 amorpha-4,11-diene strain led to production of > 40 g/L product. A chemical process was developed to convert amorpha-4,11-diene to dihydroartemisinic acid, which could subsequently be converted to artemisinin. The strains and procedures described represent a complete process for production of semisynthetic artemisinin.Keywords
This publication has 34 references indexed in Scilit:
- You're one in a googol: optimizing genes for protein expressionJournal of The Royal Society Interface, 2009
- High-Level Production of Amorpha-4,11-Diene, a Precursor of the Antimalarial Agent Artemisinin, in Escherichia coliPLOS ONE, 2009
- Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acidBMC Biotechnology, 2008
- Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapiesMalaria Journal, 2008
- Application of Functional Genomics to Pathway Optimization for Increased Isoprenoid ProductionApplied and Environmental Microbiology, 2008
- Qinghaosu (Artemisinin): The Price of SuccessScience, 2008
- A Role for Sterol Levels in Oxygen Sensing in Saccharomyces cerevisiaeGenetics, 2006
- Production of the antimalarial drug precursor artemisinic acid in engineered yeastNature, 2006
- Four Linked Genes Participate in Controlling Sporulation Efficiency in Budding YeastPLoS Genetics, 2006
- Development of a Large-Scale Process for an HIV Protease InhibitorOrganic Process Research & Development, 1997